Xiaobei Mao
Impact in
-
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
-
- Chemokine receptors and signaling
Papers in
-
- FOXO transcription factor regulation 3
- Circular RNAs in diseases 3
- Oncology 5
- Chemokine receptors and signaling 2
- Colorectal Cancer Surgical Treatments 1
- Co-authors
- Lijun Xue (10 shared papers)Xiaoyuan Chu (9 shared papers)Xiang Liu (5 shared papers)Longbang Chen (6 shared papers)Lili Ren (2 shared papers)Kai Xu (2 shared papers)Tao Xie (2 shared papers)Rui Wang (1 shared paper)
- Journals
- Cancer Medicine (2 papers)Cellular Physiology and Biochemistry (2 papers)Cancer Biology & Therapy (1 paper)Phytotherapy Research (1 paper)Oncotarget (1 paper)
- Partner nations
- China
In The Last Decade
Xiaobei Mao
11 papers receiving 347 citations
Peers
Comparison fields: 5 of 56
- Cancer Research 151
- Oncology 112
- Molecular Biology 232
- Immunology 52
- Pathology and Forensic Medicine 31
Countries citing papers authored by Xiaobei Mao
This map shows the geographic impact of Xiaobei Mao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaobei Mao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaobei Mao more than expected).
Fields of papers citing papers by Xiaobei Mao
This network shows the impact of papers produced by Xiaobei Mao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaobei Mao. The network helps show where Xiaobei Mao may publish in the future.
Co-authors
The 25 scholars most cited alongside Xiaobei Mao, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2015 | 75 | |
| 2 | 2017 | 65 | |
| 3 | 2016 | 59 | |
| 4 | 2016 | 58 | |
| 5 | 2014 | 37 | |
| 6 | Expression of chemokine receptor CXCR7 in colorectal carcinoma and its prognostic significance. | 2015 | 21 |
| 7 | 2019 | 16 | |
| 8 | 2021 | 14 | |
| 9 | 2017 | 2 | |
| 10 | 2024 | 2 | |
| 11 | [Genome-wide screening of CpG island methylation changes induced by low-dose X-ray radiation in mice]. | 2014 | 1 |
| 12 | 2010 | 0 |
About Xiaobei Mao
Xiaobei Mao is a scholar working on Molecular Biology, Oncology, Surgery, Immunology and Cancer Research, having authored 12 papers that have together received 350 indexed citations. Recurring topics across this work include FOXO transcription factor regulation (3 papers), Circular RNAs in diseases (3 papers), MicroRNA in disease regulation (2 papers), Immunotherapy and Immune Responses (2 papers), Effects of Radiation Exposure (2 papers), Chemokine receptors and signaling (2 papers), Pancreatic function and diabetes (1 paper) and Colorectal Cancer Surgical Treatments (1 paper). The work is most often cited by research in Cancer Research (151 citations), Oncology (112 citations), Molecular Biology (232 citations), Immunology (52 citations) and Pathology and Forensic Medicine (31 citations). Xiaobei Mao has collaborated with scholars based in China. Frequent co-authors include Lijun Xue, Xiaoyuan Chu, Xiang Liu, Longbang Chen, Lili Ren, Kai Xu, Tao Xie, Rui Wang, Lijun Xue and Tingting Dai. Their work appears in journals such as Cancer Medicine, Cellular Physiology and Biochemistry, Cancer Biology & Therapy, Phytotherapy Research and Oncotarget.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.